Corley Jesse Anderson 4

What Happened
Jesse Corley (reported as Corley Jesse Anderson), a director of RxSight, received a grant of 37,037 restricted stock units (RSUs) on June 17, 2026. The filing lists the transaction as an award/acquisition (code A); no per-share price or immediate cash value is reported because these are RSUs, not an open-market trade or option exercise.

Key Details

• Transaction date: June 17, 2026; Form 4 filed June 18, 2026 (timely — within reporting window).
• Award: 37,037 RSUs. Each RSU converts to one share of RxSight common stock (footnote 1).
• Vesting: 100% of the RSUs vest on the earlier of (i) one year after the grant date or (ii) the next annual meeting of stockholders, provided Corley continues as an Outside Director (footnote 2).
• Ownership after transaction: not specified in the provided summary.
• Other holdings: filing notes shares held by Andy Corley Living Trust, The Corley Foundation, and a trust for which his spouse is trustee; Corley may share voting/investment power over some of these (footnotes 3–5).
• Remarks: Exhibit 24 (Power of Attorney) referenced.

Context
RSU grants are long-term compensation that become ordinary shares only after vesting; they do not represent an immediate sale or purchase. This grant increases Corley’s potential future ownership if he remains on the board through the vesting condition. There’s no indication of a sale or tax-withholding disposition in this filing.